Therapeutic effects of tetramethylpyrazine nitrone in rat ischemic stroke models

Journal of Neuroscience Research

Volumn 90, Issue 8, 2012, Pages 1662-1669

  Sun, Yewei ^a   Yu, Pei ^a   Zhang, Gaoxiao ^a   Wang, Liang ^a   Zhong, Haijing ^a   Zhai, Ziyuan ^a   Wang, Linda ^a   Wang, Yuqiang ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Calcium blockade; Free radical scavenger; Ischemic stroke; Middle cerebral artery occlusion; Thrombolysis

Indexed keywords

CALCIUM ION; FREE RADICAL; NITRONE DERIVATIVE; TETRAMETHYLPYRAZINENITRONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICAL SCAVENGERS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROPROTECTIVE AGENTS; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION;

EID: 84862784980     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23034     Document Type: Article

References (38)

1. Cao X, Phillis JW. 1994. α-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res 2: 267-272.
2. Chen KJ, Chen K. 1992. Ischemic stroke treated with Ligusticum chuanxiong. Chin Med J 105: 870-873.
3. Cheng XR, Zhang L, Hu JJ, Sun L, Du GH. 2007. Neuroprotective effects of tetramethylpyrazine on hydrogen peroxide-induced apoptosis in PC12 cells. Cell Biol Int 31: 438-443.
4. Durand G, Choteau F, Pucci B, Villamena FA. 2008. Reactivity of superoxide radical anion and hydroperoxyl radical with alpha- phenyl-N-tert-butylnitrone (PBN) derivatives. J Phys Chem A 112: 12498-12509.
5. Endoh H, Kato N, Fujii S, Suzuki Y, Sato S, Kayama T, Kotake Y, Yoshimura T. 2001. Spin trapping agent, phenyl N-tert-butylnitrone, reduces nitric oxide production in the rat brain during experimental meningitis. Free Radic Res 35: 583-591.
6. Floyd RA. 2006. Nitrones as therapeutics in age-related diseases. Aging Cell 5: 51-57.
7. Green AR, Lanbeck-Vallén K, Ashwood T, Lundquist S, Lindström Böö E, Jonasson H, Campbell M. 2006. Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemia. Brain Res 1072: 224-226.
8. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D, ECASS Investigators. 2008. Thrombolysis with alteplase 3 to 4.5 hr after acute ischemic stroke. N Engl J Med 359: 1317-1329.
9. Hara H, Huang PL, Panahian N, Fishman MC, Moskowitz MA. 1996. Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. JCereb Blood Flow Metab 16: 605-611.
10. Horn J, de Haan RJ, Vermeulen M, Limburg M. 2001. Very early Nimodipine use in stroke (VENUS): a randomized, double-blind, placebo-controlled trial. Stroke 32: 461-465.
11. Lakhan SE, Kirchgessner A, Hofer M. 2009. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7: 97.
12. Li SY, Jia YH, Sun WG, Tang Y, An GS, Ni JH, Jia HT. 2010. Stabilization of mitochondrial function by tetramethylpyrazine protects against kainate-induced oxidative lesions in the rat hippocampus. Free Radic Biol Med 48: 597-608.
13. Lin TN, He YY, Wu G, Khan M, Hsu CY. 1993. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24: 117-121.
14. Liu SY, Sylvester DM. 1990. Antithrombotic/antiplatelet activity of tetramethylpyrazine. Thromb Res 58: 129-140.
15. Longa EZ, Weinstein PR, Carlson S, Cummins R. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1: 84-91.
16. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 2006. 1, 026 experimental treatments in acute stroke. Ann Neurol 3: 467-477.
17. Shichinohe H, Kuroda S, Abumiya T, Ikeda J, Kobayashi T, Yoshimoto T, Iwasaki Y. 2004. FK506 reduces infarct volume due to permanent focal cerebral ischemia by maintaining BAD turnover and inhibiting cytochrome c release. Brain Res 1001: 51-59.
18. Su MH, Zhou YG, Yang GT. 2008. Effect of tetramethylpyrazine on L-type "calcium-channel current" and intracellular calcium concentration in primary cultured hippocampal neuronal cells. Chin J Rehabil 23: 17-19.
19. Sugimoto K, Kissin I, Strichartz G. 2008. A high concentration of resiniferatoxin inhibits ion channel function in clonal neuroendocrine cells. Anesth Analg 107: 318-324.
20. Sun YW, Jiang J, Zhang ZJ, Yu P, Wang LD, Xu CL, Liu W, Wang YQ. 2008. Antioxidative and thrombolytic TMP nitrone for treatment of ischemic stroke. Bioorg Med Chem 16: 8868-8874.
21. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. 1990. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10: 290-293.
22. Thomas CE, Ohlweiler DF, Carr AA, Nieduzak TR, Hay DA, Adams G, Vaz R, Bernotas RC. 1996. Characterization of the radical trapping activity of a novel series of cyclic nitrone spin traps. J Biol Chem 6: 3097-3104.
23. Uematsu D, Greenberg JH, Hickey WF, Reivich M. 1989. Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats. Stroke 20: 1531-1537.
24. Van Dyke K, McConnell P, Marquardt L. 2000. Green tea extract and its polyphenols markedly inhibit luminol-dependent chemiluminescence activated by peroxynitrite or SIN-1. Luminescence 15: 37-43.
25. Von Gadow A, Joubert E, Hansmann CF. 1997. Comparison of antioxidant activity of aspalathin with that of other plant phenols of rooibos tea (Aspalathus linearis), alpha-tocopherol, BHT and BHA. J Agric Food Chem 3: 632-638.
26. Wang CX, Shuaib A. 2004. NXY-059: a neuroprotective agent in acute stroke. Int J Clin Pract 58: 964-969.
27. Wang PH, Zweier JL. 1996. Measurement of nitric oxide and peroxynitrite generation in the pstischemic heart. J Biol Chem 271: 29223-29230.
28. 2+ signaling in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurosci Lett 376: 127-132.
29. Yong-Kee CJ, Salomonczyk D, Nash JE. 2011. Development and validation of a screening assay for the evaluation of putative neuroprotective agents in the treatment of Parkinson's disease. Neurotox Res 19: 519-526.
30. Young AR, Ali C, Duretête A, Vivien D. 2007. Neuroprotection and stroke: time for a compromise. J Neurochem 103: 1302-1309.
31. Zhang HD, Chen M, Ma L. 2004. The inhibition on pyrogallol autoxidation of diterpenoid tanshinones from Salvia miltiorrhiza Bge. Pharmacol Clin Chin Mater Med 4: 16-19.
32. Zhang ZH, Yu SZ, Wang ZT, Zhao BL, Hou JW, Yang FJ, Xin WJ. 1994. Scavenging effects of tetramethylpyrazine on active oxygen free radicals. Zhongguo Yao Li Xue Bao 15: 229-231.
33. Zhang Z, Wei T, Hou J, Li G, Yu S, Xin W. 2003. Tetramethylpyrazine scavenges superoxide anion and decreases nitric oxide production in human polymorphonuclear leukocytes. Life Sci 72: 2465-2472.
34. Zhao Q, Pahlmark K, Smith ML, Siesjo BK. 1994. Delayed treatment with the spin trap α-phenyl-N-tert-butyl nitrone (PBN) reduced infarct size following transient middle cerebral artery occlusion in rats. Acta Physiol Scand 3: 349-350.
35. Zhou L, Li F, Xu HB, Luo CX, Wu HY, Zhu MM, Lu W, Ji X, Zhou QG, Zhu DY. 2010. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Nat Med 16: 1439-1443.
36. Zhou XZ, Salganicoff L, Sevy R. 1985. The pharmacological effect of ligustrazine on human platelets. Acta Pharm Sin 20: 334-339.
37. Zhu XL, Xiong LZ, Wang Q, Liu ZG, Ma X, Zhu ZH, Hu S, Gong G, Chen SY. 2009. Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats. Neurosci Lett 449: 24-27.
38. Zou LY, Hao XM, Zhang GQ, Zhang M, Guo JH, Liu TF. 2001. Effect of tetramethylpyrazine on L-type calcium channel in rat ventricular myocytes. Can J Physiol Pharmacol 79: 621-626.